Institutional Ownership
Immunome Inc
CUSIP 45257U108COMIMNMQ1 2026
13D / 13G Filings
45
Schedule 13D/13G on record
Beneficial Filers
19
Distinct reporting persons
Largest Stake
20.0%
Max % of class reported
Institutional Holders
192
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
45 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Redmile Group, LLC | 13G/A | 5.2% | 57.18M | SEC |
| 2 | Dec 22, 2025 | Enavate Sciences Gp, LLC | 13D/A | 4.3% | — | SEC |
| 3 | Nov 7, 2025 | T. Rowe Price Investment Management, Inc. | 13G | 12.2% | 10.64M | SEC |
| 4 | Oct 7, 2025 | Fmr LLC | 13G/A | 15.0% | 13.06M | SEC |
| 5 | Aug 6, 2025 | Fmr LLC | 13G | 7.1% | 6.17M | SEC |
| 6 | Jul 29, 2025 | The Vanguard Group | 13G | 5.2% | 4.52M | SEC |
| 7 | May 15, 2025 | Redmile Group, LLC | 13G/A | 6.2% | 5.36M | SEC |
| 8 | May 15, 2025 | Ecor1 Capital, LLC | 13G/A | 4.7% | — | SEC |
| 9 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 2.2% | 1.91M | SEC |
| 10 | May 12, 2025 | Fmr LLC | 13G/A | 4.5% | 3.89M | SEC |
35 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Immunome Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 16.97M | $371.13M |
| 2 | Blackrock, Inc. | 8.17M | $178.65M |
| 3 | Redmile Group, LLC | 5.56M | $121.57M |
| 4 | State Street Corp | 5.40M | $118.10M |
| 5 | Primecap Management Co/Ca/ | 4.79M | $104.72M |
| 6 | Wellington Management Group LLP | 4.73M | $103.49M |
| 7 | Driehaus Capital Management LLC | 4.10M | $89.66M |
| 8 | Enavate Sciences Gp, LLC | 3.61M | $79.03M |
| 9 | Morgan Stanley | 2.84M | $62.15M |
| 10 | Geode Capital Management, LLC | 2.56M | $56.01M |